Biotech | April 12, 2022
ReiThera and Exothera collaborate to develop large-scale, low cost per dose vaccine
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Collaboration awarded €3 million grant by the Bill & Melinda Gates Foundation
Collaboration to target bacterial and viral pathogens including HIV, SARS-CoV-2, antimicrobial-resistant pathogens, and tuberculosis
Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms
The new reagents will bring the exceptional sensitivity of the company’s liquid format 1-step RT-qPCR reagents to a freeze-dryable format
Primarily set up to address the Covid-19 emergency, the WHO technology transfer hub has the potential to expand manufacturing capacity for other products as well, including treatments, and target other priorities such as malaria, HIV and cancer
The mAbxience partnership will enable Cipla to continue its ethos of ensuring equitable access to affordable, life-saving medication
It is a point-of-care portable, battery-operated, IoT-enabled platform with a sample to result in less than 1 hour
The company is investing up to US $ 500 million to produce up to 500 million doses each year for the African continent
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
Launched in 2020, C-TAP aims to facilitate timely, equitable and affordable access to Covid-19 health products by boosting their production and supply through open, non-exclusive licensing agreements
Subscribe To Our Newsletter & Stay Updated
